Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells

39Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

According to common beliefs, conventional anticancer chemotherapy is deleterious for the immune system. We have recently provided in vitro evidence indicating that conventional chemotherapy may potentiate, rather than impair, the long-term efficacy of γδ T cell-based anticancer immunotherapy. © 2013 Landes Bioscience.

Cite

CITATION STYLE

APA

Todaro, M., Meraviglia, S., Caccamo, N., Stassi, G., & Dieli, F. (2013). Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells. OncoImmunology, 2(9). https://doi.org/10.4161/onci.25821

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free